SURMOUNT-1 enrolled 2,539 adults with obesity or overweight
If youre ready to take proactive steps toward better health, contact Family Health Care to schedule your consultation with Dr
The resources and costs are reported in Table 1
7583% achieved 15% 26% of participants on 12 mg achieved 30% weight reduction Cardiometabolic Parameters Improvements in blood pressure, HbA1c, fasting glucose, insulin, LDL-cholesterol 72% of patients with prediabetes achieved normoglycemia Safety Most common adverse events: gastrointestinal (nausea, diarrhea, constipation) , dose-dependent, predominantly mild to moderate Heart rate: slight increase up to week 24, then decrease No severe hypoglycemia, medullary carcinoma, or C-cell hyperplasia Conclusions Retatrutide induced significant, dose-dependent weight reduction of up to 24.2% over 48 weeks
Supporters point to a large real-world usage record with few reported problems
Reactive oxygen species in inflammation and tissue injury
